Pharmacokinetic/pharmacodynamic modeling of roxadustat's effect on LDL cholesterol in patients in Japan with dialysis-dependent chronic kidney disease and anemia

This publication has 24 references indexed in Scilit:

• Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice
  Journal of Lipid Research, 2016
• Population pharmacodynamic analysis of LDL‐cholesterol lowering effects by statins and co‐medications based on electronic medical records
  British Journal of Clinical Pharmacology, 2014
• Effects of Switching From Sevelamer Hydrochloride to Bixalomer on Laboratory Parameters in Hemodialysis Patients
  Therapeutic Apheresis and Dialysis, 2014
• Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients
  Therapeutic Apheresis and Dialysis, 2013
• A Population Pharmacokinetic–Pharmacodynamic Model for Simvastatin that Predicts Low‐Density Lipoprotein‐Cholesterol Reduction in Patients with Primary Hyperlipidaemia
  Basic & Clinical Pharmacology & Toxicology, 2011
• Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
  American Heart Journal, 2010
• Cardiovascular Death in Dialysis Patients
  Clinical Journal of the American Society of Nephrology, 2010
• Hypoxia Stimulates Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase through Accumulation of Lanosterol and Hypoxia-Inducible Factor-mediated Induction of Insigs
  Journal of Biological Chemistry, 2007
• Derivation of various NONMEM estimation methods
  Journal of Pharmacokinetics and Pharmacodynamics, 2007
• Modelling Response Time Profiles in the Absence of Drug Concentrations: Definition and Performance Evaluation of the K–PD Model
  Journal of Pharmacokinetics and Pharmacodynamics, 2006